Clinical trial
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
NCT00001646 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001646 |
|---|---|
| Title | Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis |
| Official title | Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acquired Immunodeficiency Syndrome, Aspergillosis, HIV Infections, Immunologic Deficiency Syndromes, Neutropenia |
| Intervention type | Drug |
| Interventions | Voriconazole, Amphotericin B |
| Enrollment | 10 |
| Start date | Aug 1, 1997 |
| Completion | Aug 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: